Manager, Revenue Accounting

Compass Pathways•Jersey City, NJ

4d•$140,000 - $190,000•Hybrid

About The Position

The Manager, Revenue Accounting will help prepare Compass Pathways for the transition from a clinical-stage biotechnology company to a commercial organization. The role will establish and manage scalable revenue accounting processes, policies, systems, and controls in support of potential commercialization. It will lead the accounting framework for the order-to-cash cycle, including revenue recognition, gross-to-net accounting, customer and distribution arrangements, accounts receivable, and related financial reporting. The position partners with Commercial Operations, Market Access, Supply Chain, Legal, FP&A, Tax, Finance Operations, external auditors, and advisors to ensure evolving commercial arrangements are appropriately reflected in the Company’s accounting and control environment. It is hybrid in the Jersey City office or remote on the East Coast in the United States, and reports to Accounting Senior Management.

Requirements

Bachelor’s degree in Accounting, Finance, or a related field.
Approximately 7 or more years of relevant accounting experience, with flexibility depending on the successful candidate’s level.
Strong technical knowledge of U.S. GAAP, particularly ASC 606, with demonstrated experience applying revenue recognition guidance to commercial arrangements and variable consideration.
Hands-on experience with U.S. pharmaceutical or biopharmaceutical product revenue accounting, including gross-to-net accounting, reconciliations, and related controls.
Experience supporting quarterly and annual financial reporting and external audits, with hands-on ownership and operation of SOX controls and preparation of supporting documentation in a public company environment.
Strong analytical skills and ability to develop and document significant accounting estimates and translate complex commercial arrangements into clear accounting conclusions and operational processes.
Ability to work independently, build new processes, partner effectively with Finance and non-Finance stakeholders, and communicate technical accounting matters clearly.
Demonstrates Compass values.

Nice To Haves

CPA or equivalent professional accounting qualification.
Experience preparing a biotechnology or pharmaceutical company for its first commercial product launch.
Knowledge of pharmaceutical gross-to-net arrangements, including payer rebates, government programs, chargebacks, returns, discounts, and distribution-related fees.
Experience accounting for and reconciling government and commercial rebate activity.
Experience with specialty pharmacy, specialty distribution, and/or third-party logistics models.
Experience implementing or enhancing ERP, revenue, gross-to-net, or other commercial accounting systems.
Public accounting and SEC reporting experience.

Responsibilities

Lead the development and implementation of scalable revenue accounting processes, policies, and controls in preparation for potential U.S. commercialization.
Own accounting assessments of commercial arrangements under ASC 606, including customer contract reviews and documentation of significant accounting judgments.
Develop and maintain the gross-to-net accounting framework, including methods for estimating and recording rebates, discounts, chargebacks, distribution fees, returns, and other deductions; coordinate sourcing, validation, and processing of supporting data.
Partner with Commercial Operations, Market Access, Legal, and Supply Chain to evaluate proposed pricing, contracting, distribution, specialty pharmacy, and other commercial arrangements and identify accounting, data, and control implications.
Establish accounting processes for product sales through distribution and pharmacy channels, including revenue recognition, inventory movement, channel-data reconciliation, customer payment terms, and accounts receivable, in partnership with the 3PL and other process owners.
Lead the revenue accounting workstream, identify accounting, systems, data, and control requirements for a potential first product launch, and help drive cross-functional launch readiness.
Own or oversee monthly and quarterly revenue accounting activities, including journal entries, account reconciliations, gross-to-net accruals, and related account analyses.
Develop and maintain revenue-related accounting policies, technical accounting memos, and audit-ready documentation supporting significant estimates, judgments, changes in assumptions, and gross-to-net reserve methodologies, data, and controls.
Establish processes for timely Finance review of new or modified commercial agreements before execution, including assessment of revenue recognition, gross-to-net, systems, and internal-control implications.
Establish and maintain SOX-compliant controls over revenue, gross-to-net estimates, accounts receivable, and related commercial processes, including complete, audit-ready control evidence.
Develop processes to compare actual gross-to-net activity with recorded estimates, analyze variances, and refine assumptions as commercial experience develops.
Support financial statement disclosures and management reporting related to revenue and associated balance-sheet accounts.
Partner with external auditors and advisors on revenue accounting and provide documentation for quarterly reviews, annual audits, and control testing.
Partner with Finance Operations, IT, and Commercial Operations to define systems, master data, interfaces, and reporting needed for the order-to-cash process.
Establish processes to capture and reconcile data from distributors, specialty pharmacies, third-party logistics providers, and other commercial partners.
Work with FP&A to support revenue and gross-to-net forecasting, assess accounting assumptions, and explain actual-to-forecast variances.
Collaborate with Supply Chain on the interaction between revenue recognition, inventory, and cost of goods sold, including transfer-of-control considerations.
Identify opportunities to automate revenue accounting processes, improve data integrity, and strengthen controls as commercial transaction volumes increase.